Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 17 | 2023 | 158 | 1.820 |
Why?
|
| Microbiota | 15 | 2024 | 95 | 1.690 |
Why?
|
| Vaginosis, Bacterial | 6 | 2024 | 29 | 1.130 |
Why?
|
| Staphylococcal Infections | 7 | 2022 | 162 | 1.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 6 | 2021 | 119 | 0.860 |
Why?
|
| HIV Infections | 3 | 2022 | 466 | 0.760 |
Why?
|
| Circadian Rhythm | 5 | 2022 | 235 | 0.640 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 123 | 0.620 |
Why?
|
| Feces | 10 | 2023 | 103 | 0.580 |
Why?
|
| Dysbiosis | 5 | 2018 | 45 | 0.500 |
Why?
|
| Oligosaccharides | 3 | 2021 | 18 | 0.500 |
Why?
|
| Inflammation | 4 | 2021 | 272 | 0.460 |
Why?
|
| Colon | 6 | 2023 | 119 | 0.450 |
Why?
|
| Parkinson Disease | 4 | 2023 | 670 | 0.390 |
Why?
|
| Humans | 37 | 2024 | 27072 | 0.370 |
Why?
|
| Prebiotics | 3 | 2023 | 22 | 0.350 |
Why?
|
| Herpes Genitalis | 2 | 2022 | 6 | 0.350 |
Why?
|
| Sexual and Gender Minorities | 2 | 2021 | 27 | 0.340 |
Why?
|
| Male | 27 | 2022 | 14772 | 0.340 |
Why?
|
| Genomics | 5 | 2021 | 64 | 0.340 |
Why?
|
| Saliva | 2 | 2022 | 52 | 0.330 |
Why?
|
| Animals | 14 | 2023 | 3642 | 0.330 |
Why?
|
| Eating | 2 | 2021 | 58 | 0.330 |
Why?
|
| Intestines | 3 | 2021 | 80 | 0.320 |
Why?
|
| Food Hypersensitivity | 2 | 2021 | 43 | 0.310 |
Why?
|
| Female | 25 | 2024 | 15212 | 0.310 |
Why?
|
| Starch | 2 | 2019 | 10 | 0.300 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2024 | 58 | 0.290 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 599 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 8 | 2023 | 420 | 0.280 |
Why?
|
| Dietary Fiber | 2 | 2017 | 27 | 0.280 |
Why?
|
| Vagina | 2 | 2024 | 35 | 0.270 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 75 | 0.270 |
Why?
|
| Cross Infection | 2 | 2021 | 301 | 0.260 |
Why?
|
| Colon, Sigmoid | 2 | 2017 | 15 | 0.260 |
Why?
|
| Sinusitis | 2 | 2018 | 162 | 0.250 |
Why?
|
| Menstrual Hygiene Products | 2 | 2023 | 5 | 0.250 |
Why?
|
| Colitis | 2 | 2023 | 30 | 0.250 |
Why?
|
| Herpesvirus 2, Human | 3 | 2022 | 7 | 0.250 |
Why?
|
| Milk, Human | 2 | 2019 | 201 | 0.240 |
Why?
|
| Ulcer | 2 | 2017 | 7 | 0.240 |
Why?
|
| Rain | 1 | 2024 | 2 | 0.240 |
Why?
|
| Toilet Facilities | 1 | 2024 | 2 | 0.240 |
Why?
|
| Bacteria | 3 | 2024 | 70 | 0.230 |
Why?
|
| Mice | 8 | 2023 | 1395 | 0.230 |
Why?
|
| Immune System | 2 | 2021 | 15 | 0.230 |
Why?
|
| Circumcision, Male | 2 | 2022 | 8 | 0.220 |
Why?
|
| Enterobacteriaceae | 2 | 2024 | 45 | 0.220 |
Why?
|
| Laboratories, Hospital | 1 | 2024 | 5 | 0.220 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2023 | 17 | 0.210 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 14 | 0.210 |
Why?
|
| Community-Acquired Infections | 2 | 2021 | 69 | 0.210 |
Why?
|
| Kenya | 5 | 2023 | 11 | 0.200 |
Why?
|
| Circumcision, Female | 1 | 2022 | 2 | 0.200 |
Why?
|
| Butyrates | 2 | 2019 | 17 | 0.200 |
Why?
|
| Biodiversity | 2 | 2019 | 35 | 0.190 |
Why?
|
| Shift Work Schedule | 1 | 2022 | 9 | 0.190 |
Why?
|
| Mouth | 1 | 2022 | 14 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 21 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2021 | 66 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2018 | 33 | 0.180 |
Why?
|
| Universities | 1 | 2021 | 39 | 0.180 |
Why?
|
| Milk | 1 | 2021 | 14 | 0.180 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 80 | 0.180 |
Why?
|
| Schistosomiasis | 1 | 2021 | 7 | 0.180 |
Why?
|
| Students | 1 | 2021 | 48 | 0.180 |
Why?
|
| Adult | 11 | 2022 | 7831 | 0.180 |
Why?
|
| Animal Husbandry | 1 | 2020 | 8 | 0.180 |
Why?
|
| Ethanol | 3 | 2019 | 86 | 0.180 |
Why?
|
| Macaca mulatta | 1 | 2020 | 60 | 0.170 |
Why?
|
| Weight Gain | 1 | 2020 | 64 | 0.170 |
Why?
|
| Fresh Water | 1 | 2020 | 5 | 0.170 |
Why?
|
| Young Adult | 6 | 2024 | 1994 | 0.170 |
Why?
|
| Phenotype | 1 | 2021 | 312 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 4 | 2023 | 31 | 0.170 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 62 | 0.160 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2020 | 57 | 0.160 |
Why?
|
| Trisaccharides | 1 | 2019 | 3 | 0.160 |
Why?
|
| Astronauts | 1 | 2019 | 4 | 0.160 |
Why?
|
| Space Flight | 1 | 2019 | 6 | 0.160 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 12 | 0.160 |
Why?
|
| Colonic Polyps | 1 | 2019 | 29 | 0.160 |
Why?
|
| Microglia | 1 | 2020 | 143 | 0.160 |
Why?
|
| Mucous Membrane | 1 | 2019 | 29 | 0.160 |
Why?
|
| Osteolysis | 1 | 2020 | 139 | 0.160 |
Why?
|
| Specimen Handling | 1 | 2019 | 44 | 0.160 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 47 | 0.160 |
Why?
|
| Firmicutes | 1 | 2019 | 6 | 0.160 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 154 | 0.160 |
Why?
|
| Rotenone | 1 | 2018 | 9 | 0.160 |
Why?
|
| Feeding Behavior | 1 | 2019 | 85 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2019 | 45 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 30 | 0.150 |
Why?
|
| Photoperiod | 2 | 2019 | 30 | 0.150 |
Why?
|
| Tea | 1 | 2018 | 6 | 0.150 |
Why?
|
| Mouth Mucosa | 1 | 2018 | 13 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2019 | 156 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2018 | 21 | 0.150 |
Why?
|
| Adolescent | 5 | 2024 | 2172 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 22 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 185 | 0.150 |
Why?
|
| Rhinitis, Allergic | 1 | 2018 | 16 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2018 | 46 | 0.140 |
Why?
|
| Antioxidants | 1 | 2018 | 63 | 0.140 |
Why?
|
| Obesity | 1 | 2020 | 311 | 0.140 |
Why?
|
| Nose | 1 | 2018 | 38 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 5 | 0.140 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 14 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 26 | 0.140 |
Why?
|
| Sleep | 1 | 2020 | 328 | 0.140 |
Why?
|
| Pilot Projects | 4 | 2020 | 420 | 0.140 |
Why?
|
| Parkinsonian Disorders | 1 | 2020 | 225 | 0.140 |
Why?
|
| Rhinitis | 1 | 2018 | 144 | 0.130 |
Why?
|
| Multiple System Atrophy | 1 | 2017 | 32 | 0.130 |
Why?
|
| Bacteremia | 1 | 2017 | 101 | 0.130 |
Why?
|
| Asthma | 1 | 2018 | 156 | 0.130 |
Why?
|
| Chicago | 4 | 2021 | 949 | 0.130 |
Why?
|
| Circadian Clocks | 1 | 2016 | 22 | 0.120 |
Why?
|
| Brain | 2 | 2021 | 1649 | 0.120 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2015 | 48 | 0.110 |
Why?
|
| Alcoholism | 1 | 2015 | 67 | 0.110 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 130 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2024 | 1778 | 0.100 |
Why?
|
| Bacteria, Anaerobic | 1 | 2012 | 1 | 0.100 |
Why?
|
| Genital Diseases, Male | 1 | 2012 | 8 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2012 | 51 | 0.100 |
Why?
|
| Time Factors | 3 | 2020 | 1433 | 0.090 |
Why?
|
| Sexual Partners | 2 | 2022 | 17 | 0.090 |
Why?
|
| Staphylococcus aureus | 2 | 2022 | 69 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 87 | 0.090 |
Why?
|
| Homosexuality, Male | 2 | 2021 | 28 | 0.090 |
Why?
|
| Illinois | 2 | 2021 | 250 | 0.080 |
Why?
|
| Prevalence | 2 | 2021 | 443 | 0.080 |
Why?
|
| Carcinogenesis | 2 | 2019 | 22 | 0.080 |
Why?
|
| Molecular Epidemiology | 2 | 2021 | 28 | 0.080 |
Why?
|
| Phylogeny | 2 | 2021 | 51 | 0.080 |
Why?
|
| Middle Aged | 5 | 2018 | 8923 | 0.070 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 13 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 58 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2018 | 415 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 120 | 0.060 |
Why?
|
| Sanitation | 1 | 2024 | 2 | 0.060 |
Why?
|
| Hygiene | 1 | 2024 | 12 | 0.060 |
Why?
|
| Child | 2 | 2020 | 1295 | 0.060 |
Why?
|
| Public Health Surveillance | 1 | 2024 | 11 | 0.060 |
Why?
|
| Public Health | 1 | 2024 | 69 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 292 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2023 | 9 | 0.050 |
Why?
|
| Schools | 1 | 2023 | 43 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 12 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 100 | 0.050 |
Why?
|
| Travel-Related Illness | 1 | 2021 | 3 | 0.050 |
Why?
|
| Methicillin | 1 | 2021 | 7 | 0.050 |
Why?
|
| Molecular Typing | 1 | 2021 | 11 | 0.050 |
Why?
|
| Pasteurization | 1 | 2021 | 3 | 0.050 |
Why?
|
| Leptin | 1 | 2020 | 21 | 0.040 |
Why?
|
| Cadherins | 1 | 2020 | 34 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 336 | 0.040 |
Why?
|
| Fusobacteria | 1 | 2020 | 2 | 0.040 |
Why?
|
| Anilides | 1 | 2020 | 5 | 0.040 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2020 | 20 | 0.040 |
Why?
|
| Neurotoxins | 1 | 2020 | 16 | 0.040 |
Why?
|
| Food | 1 | 2020 | 34 | 0.040 |
Why?
|
| Glucose | 1 | 2020 | 49 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 124 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 33 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2020 | 19 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 46 | 0.040 |
Why?
|
| Waste Disposal, Fluid | 1 | 2020 | 4 | 0.040 |
Why?
|
| Water Microbiology | 1 | 2020 | 10 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 94 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Insulin | 1 | 2020 | 89 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2020 | 104 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 87 | 0.040 |
Why?
|
| Infection Control | 1 | 2021 | 168 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2019 | 11 | 0.040 |
Why?
|
| Period Circadian Proteins | 1 | 2019 | 15 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 26 | 0.040 |
Why?
|
| Freezing | 1 | 2019 | 14 | 0.040 |
Why?
|
| Penis | 1 | 2020 | 81 | 0.040 |
Why?
|
| Galactose | 1 | 2019 | 4 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 189 | 0.040 |
Why?
|
| Fructose | 1 | 2019 | 6 | 0.040 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2019 | 2 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 2 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2019 | 77 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2019 | 8 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2019 | 15 | 0.040 |
Why?
|
| Cecum | 1 | 2019 | 12 | 0.040 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2019 | 18 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 18 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2020 | 98 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2019 | 27 | 0.040 |
Why?
|
| Solanum tuberosum | 1 | 2019 | 3 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 33 | 0.040 |
Why?
|
| DNA Damage | 1 | 2019 | 29 | 0.040 |
Why?
|
| CD3 Complex | 1 | 2018 | 4 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 219 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2019 | 29 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 261 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 56 | 0.040 |
Why?
|
| Rats | 1 | 2020 | 664 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2019 | 40 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 80 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 134 | 0.040 |
Why?
|
| Gingiva | 1 | 2018 | 3 | 0.040 |
Why?
|
| Streptococcus | 1 | 2018 | 3 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 370 | 0.040 |
Why?
|
| Catechin | 1 | 2018 | 4 | 0.040 |
Why?
|
| Staphylococcus | 1 | 2018 | 10 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 71 | 0.040 |
Why?
|
| Epithelium | 1 | 2018 | 31 | 0.040 |
Why?
|
| Smokers | 1 | 2018 | 12 | 0.040 |
Why?
|
| Protective Agents | 1 | 2018 | 10 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 18 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 28 | 0.040 |
Why?
|
| Genitalia | 1 | 2017 | 3 | 0.040 |
Why?
|
| Pancreas | 1 | 2018 | 32 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 673 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2018 | 301 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 562 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 891 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 161 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 116 | 0.040 |
Why?
|
| South Africa | 1 | 2017 | 13 | 0.040 |
Why?
|
| Fermentation | 1 | 2017 | 13 | 0.040 |
Why?
|
| Constipation | 1 | 2017 | 16 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 43 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 13 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 587 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 47 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 23 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 406 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 16 | 0.030 |
Why?
|
| Protein Folding | 1 | 2015 | 19 | 0.030 |
Why?
|
| Diet | 1 | 2017 | 220 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 564 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 1112 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 641 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 20 | 0.030 |
Why?
|
| Endotoxemia | 1 | 2015 | 20 | 0.030 |
Why?
|
| Probiotics | 1 | 2015 | 17 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 97 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2015 | 34 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 6 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 13 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 2302 | 0.030 |
Why?
|
| Light | 1 | 2014 | 57 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1890 | 0.030 |
Why?
|
| United States | 1 | 2019 | 2035 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 3 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 43 | 0.020 |
Why?
|
| Cognition | 1 | 2020 | 1339 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 3538 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 8997 | 0.010 |
Why?
|